Quarterly report pursuant to Section 13 or 15(d)

Equity-Based Compensation (Schedule Of Stock Option Activity) (Details)

v2.4.0.8
Equity-Based Compensation (Schedule Of Stock Option Activity) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Mar. 29, 2014
Dec. 28, 2013
Equity-Based Compensation [Abstract]    
Shares, Outstanding 1,827  
Shares, Granted 669  
Shares, Exercised (160)  
Shares, Forfeited (20)  
Shares, Outstanding 2,316 1,827
Shares, Exercisable 424  
Weighted-average grant price, Outstanding $ 37.37  
Weighted-average grant price, Granted $ 57.62  
Weighted-average grant price, Exercised $ 28.83  
Weighted-average grant price, Forfeited $ 27.33  
Weighted-average grant price, Outstanding $ 43.90 $ 37.37
Weighted-average grant price, Exercisable $ 37.96  
Weighted-average remaining contractual term, Outstanding 3 years 2 years 7 months 6 days
Weighted-average remaining contractual term, Exercisable 1 year 10 months 24 days  
Aggregate intrinsic value, Outstanding $ 74,160 [1]  
Aggregate intrinsic value, Outstanding 70,387 [1] 74,160 [1]
Aggregate intrinsic value, Exercisable $ 15,280 [1]  
Closing price of common stock $ 74.02 $ 77.72
[1] Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.  The closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.